Pharmacist Value-Added Service - Dr. Z - APP Exam 1

Match the following steps in pharmacist patient care process (PPCP) with their proper descriptions

• Implement

• Determining the patient's progress toward therapeutic goals, evaluating wether they have atteined the goals

• Collect

• Working with patient's physicians, nurses, and other health care providers as well as caregivers in collabaration

• Plan

• The patients med history, laboratory data, assessment findings, social history, and lifestyle habits

• Plan

• An individualized plan that address the patients medications related problems and sets goals for therapy

• Assess

• Considering all information in order to make a decision regarding the appropriateness, effectiveness, and safety of a patients therapy

Select all of the following value-added services that pharmacist can implement

• Medication therapy management

• Monitoring/screening and wellness/Health-promotion services

• Disease-state management

• Case management

• Life advice

Match the following medication therapy managements types with their descriptions

• Comprehensive

• Pharmacist proactively reviews the patient profile

• Appointment based model

• Incorporates a comprehensive review of the medication profile into medication dispensing process for all patients as rx are prescribed

• Focused MTM

• Occurs during the dispensing process when a mediation therapy problem is identified

• Continuous medication management (CMM)

• Identifies all problems with a patient's medical therapy. The workup and recommendations are shared with the patient and the physician

Categorize these different parts of the pharmacist patient care process (PPCP) into which categories they fall under

Groups:

(a) Collect

,

(b) Asess

,

(c) Plan and implement

,

(d) Follow-up

• Adherence
  

• Monitor patients progress

• Appropriatness

• Medication history

• safety

• working in collaboration with patient, caregivers, and health care team

• Social history

• Coming up with a individualized plan to help the patient

• Determining if they obtained goals

• Laboratory data

• Setting goals for therapy

• Effectiveness

• Evaluate patients progress towards therapeutic goals

• Physical assessment findings

Collaboration, communication, and documentation should only occur in the Plan, implementation and follow-up parts of the PCPP

• True

• False

All of the following are true for medication management protocols (the collaborative practice agreements) EXCEPT

• Physicians and pharmacist sign the CPA and a copy should be kept at the pharmacy or physicians practice

• CPAs should be cost-based and supported by national guidelines and the primary literature

• CPAs should be developed to help guide the pharmacists therapeutic decisions

• CPAs should be evidence-based and supported by national guidelines and primary literature

• CPAs hold no real particle place in medication management

CLIA waived test are considered by both the CDC and FDA as difficult test to administer with a higher risk of error.

• True

• False

Pharmacist providing CLIA waived test agree to follow good laboratory practices

• True

• False

Pharmacies implementing monitoring or screening services that utilize devices that measure patients specimens need to apply for which of the following

• OSHA waiver

• CLIA wavier

• HIPPA Waiver

• CDA waiver